Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1996
10/22/1996US5567677 Protein formulation comprising growth hormone
10/22/1996US5567489 Multilayer halogen-free barrier film for ostomy and transdermal drug delivery applications
10/22/1996US5567441 Sustained release pellets comprising multilayer polymeric membrane
10/22/1996US5567440 Methods for modifying cell contact with a surface
10/22/1996US5567439 Delivery of controlled-release systems(s)
10/22/1996US5567438 Dissolving in water; precipitating in acidic solution
10/22/1996US5567437 Effervescent pharmaceutical composition containing ibuprofen and its method of preparation
10/22/1996US5567435 Mixing active material with a solution of polymerizable macromer comprising degradable region and free radical polymerizable end groups
10/22/1996US5567434 Dissolving compound and lipid in aprotic sovent, extruding into aqueous solution
10/22/1996US5567433 Liposome preparation and material encapsulation method
10/22/1996US5567432 Membrane encapsulated by synthetic neumaminic acid residue;reticuloendothelial system
10/22/1996US5567431 Polylactic acid-based implant susceptible of bioresorption containing and antibiotic
10/22/1996US5567426 Cosmetic compositon in the form of a gelled triple water/silicone oil/water emulsion
10/22/1996US5567423 Animal growth promotant
10/22/1996US5567414 Image contrast agent
10/22/1996CA2109698C Long-term delivery device including hydrophobic loading dose
10/22/1996CA2106137C High efficacy aerosol antiperspirant composition
10/22/1996CA2096003C Compositions of gastric acid-resistant microspheres containing buffered bile acids
10/22/1996CA2066409C Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
10/22/1996CA2021767C Method for preparing a pharmaceutical composition in the form of microparticles
10/22/1996CA2013223C Enteral diet for patients with pulmonary disease
10/22/1996CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them
10/22/1996CA1338662C Pharmaceutical dosage form for the medication of fish
10/22/1996CA1338660C Transdermal multipolymer drug delivery system
10/17/1996WO1996032497A1 Biological reagent spheres
10/17/1996WO1996032345A1 Metered dose inhaler for beclomethasone dipropionate
10/17/1996WO1996032344A1 Metered-dose aerosol valve
10/17/1996WO1996032152A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996WO1996032151A1 Metered dose inhaler for fluticasone propionate
10/17/1996WO1996032149A1 Pulmonary delivery of aerosolized medicaments
10/17/1996WO1996032142A1 Skin patch for use in contact immunotherapy
10/17/1996WO1996032141A1 Transdermal drug delivery device for treating erectile dysfunction
10/17/1996WO1996032138A1 Methods for treating respiratory disease
10/17/1996WO1996032116A1 Compositions and methods for nucleic acid delivery to the lung
10/17/1996WO1996032113A1 Novel composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods
10/17/1996WO1996032102A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/17/1996WO1996032099A1 Metered dose inhaler for albuterol
10/17/1996WO1996032098A1 Non-immunogenic, biocompatible macromolecular membrane compositions, and methods for making and using same
10/17/1996WO1996032097A1 Solid compositions containing polyethyleneoxide and a non-amorphous active principle
10/17/1996WO1996032096A1 Powdered pharmaceutical formulations having improved dispersibility
10/17/1996WO1996032095A1 Process for the preparation of respirable particles
10/17/1996WO1996032094A1 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof
10/17/1996WO1996025491A3 Inhibition of proliferation of vascular smooth muscle cell
10/17/1996WO1996022084A3 Polymer adhesive formulation containing sorbent particles
10/17/1996CA2467462A1 Metered dose inhaler for salmeterol
10/17/1996CA2391617A1 Pharmaceutical preparation and use
10/17/1996CA2368934A1 Metered dose inhaler for fluticasone propionate
10/17/1996CA2218208A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996CA2218179A1 Metered dose inhaler for beclomethasone dipropionate
10/17/1996CA2217949A1 Metered-dose aerosol valve
10/17/1996CA2217062A1 Process for the preparation of respirable particles
10/17/1996CA2192597A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/16/1996EP0737926A1 Method for determining pharmacodynamic parameters and designing a dosing regimen for a drug
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737703A2 Hydrogel-forming , self-solvating absorbable polyester copolymers, and methods for use therefor
10/16/1996EP0737509A1 Crystallized beads of a product which can be supercooled and process to prepare them
10/16/1996EP0737508A1 Use of hydrofluorocarbon compound in an emulsion, emulsion and composition containing the same
10/16/1996EP0737477A1 Percutaneously absorbable preparation
10/16/1996EP0737473A1 Effervescent dosage form
10/16/1996EP0737472A1 Single-shot vaccine formulation
10/16/1996EP0737252A1 Gene therapy vector for the treatment of low or defective red blood cell production
10/16/1996EP0737248A1 Gene expression control
10/16/1996EP0737097A1 High internal phase water/oil emulsions and water/oil/water emulsions
10/16/1996EP0737069A1 Deuterised active agents in transdermal application
10/16/1996EP0737066A1 Transdermal device containing polyvinylpyrrolidone as solubility enhancer
10/16/1996EP0737065A1 Process for preparing solid pharmaceutical dosage forms
10/16/1996EP0737064A1 Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
10/16/1996EP0737062A1 Water-in-oil lotion containing a corticosteroid
10/16/1996EP0737052A1 Transdermal drug delivery system
10/16/1996EP0648254B1 Luminescent article with high phosphor to binder ratio and manufacture thereof
10/16/1996EP0639176B1 Benzenedimethanol suitable for micronisation
10/16/1996EP0597007B1 W/o microemulsions
10/16/1996EP0524989B1 Controlled release drug formulation
10/16/1996EP0414755B1 Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment
10/16/1996CN1133565A Pernasal composition and pernasal preparation containing the same
10/16/1996CN1133561A Stabilized prostaglandin E 1
10/16/1996CN1133558A Gelatin capsule fill able to foam
10/16/1996CN1133190A Shengfabao tablet for promoting hair growth
10/16/1996CN1133189A Oral liquid for body building up
10/16/1996CN1133188A Production method of traditional Chinese medicine pills for hyperostosis
10/16/1996CN1133187A Rufu Chinese proprietary medicine for mastoplasia and breast tumor
10/16/1996CN1133185A Hushengbaoyuanye (medicinal solution for male body promoting) formula and preparation process thereof
10/16/1996CN1133184A Ailiukangfuning Chinese proprietary medicine for cancer and preparation process
10/16/1996CN1133179A Longspur epimedium oral liquid and preparation process
10/16/1996CN1133176A Preparation process for acunthopanax senticosus powder injection
10/16/1996CN1133172A Powdered preparation for treating wounds and lesions
10/16/1996CN1033035C Method for preparing interferon alpha-2 crystals
10/15/1996US5565613 2-arylpropionic acid preparations and process for their production
10/15/1996US5565548 Peptide having sequence of protective antibody-eliciting epitope and having mercapto groups linked to carrier comprising lipid vesicle containing amino moiety activated by polyaldehyde and cysteine
10/15/1996US5565471 Method for inhibiting thrombosis
10/15/1996US5565466 Methods for modulating the human sexual response
10/15/1996US5565442 Dissolving in solvent with antioxidant and polyoxyalkyl stabilizer; compositing with carrier or excipient to impart solid characteristics; desolventizing; useful in conditions of vitamin d deficiency
10/15/1996US5565427 Stabilized factor VIII preparations
10/15/1996US5565215 Biodegradable injectable particles for imaging
10/15/1996US5565214 Stable therapeutic oil filled soft gelatin capsules
10/15/1996US5565213 Containing taurine and benzalkonium chloride in external aqueous phase and in liposome
10/15/1996US5565212 Process for producing compositions for ruminants
10/15/1996US5565209 Adjuvant mixture
10/15/1996US5565206 Ionic microbiocide absorbed, bonded on ion exchange resin
10/15/1996US5565203 Hepatitis A virus in a reconstituted influenza virosome and use as a vaccine
1 ... 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 ... 2991